SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 110 filers reported holding SUTRO BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $124,826 | -10.7% | 35,973 | +19.7% | 0.00% | – |
Q2 2023 | $139,798 | -63.4% | 30,064 | -63.6% | 0.00% | – |
Q1 2023 | $382,074 | -34.9% | 82,700 | +13.8% | 0.00% | – |
Q4 2022 | $587,117 | +9685.3% | 72,663 | +6659.3% | 0.00% | – |
Q3 2022 | $6,000 | -68.4% | 1,075 | -71.1% | 0.00% | – |
Q2 2022 | $19,000 | -97.9% | 3,723 | -96.6% | 0.00% | – |
Q1 2022 | $907,000 | +3843.5% | 110,333 | +8936.3% | 0.00% | – |
Q3 2021 | $23,000 | +91.7% | 1,221 | +140.8% | 0.00% | – |
Q1 2021 | $12,000 | +50.0% | 507 | -32.6% | 0.00% | – |
Q3 2020 | $8,000 | -81.0% | 752 | -86.0% | 0.00% | – |
Q2 2020 | $42,000 | -38.2% | 5,375 | -18.9% | 0.00% | – |
Q1 2020 | $68,000 | -54.1% | 6,628 | -50.8% | 0.00% | – |
Q4 2019 | $148,000 | +87.3% | 13,464 | +54.9% | 0.00% | – |
Q3 2019 | $79,000 | +259.1% | 8,690 | +341.1% | 0.00% | – |
Q2 2019 | $22,000 | -35.3% | 1,970 | -47.6% | 0.00% | – |
Q4 2018 | $34,000 | +78.9% | 3,758 | +201.1% | 0.00% | – |
Q3 2018 | $19,000 | – | 1,248 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |